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A B S T R A C T
Nocardia is characterised as a Gram positive ﬁlamentous rod and is found worldwide in soil, decaying
vegetable matter and aquatic environments. Localised pulmonary infection is the most common clinical
presentation. However, Nocardia can present in awide variety of clinical manifestations, especially in the
immunocompromised individual. We present the ﬁrst case of a prostate abscess caused by Nocardia
farcinica in a man with a history of severe psoriasis and psoriatic arthritis. He had been on long term
immunosuppression for this with prednisolone and etanercept. His Nocardia was likely contracted
through direct skin inoculation while gardening with haematological dissemination to the prostate. He
responded well to long term sulfamethoxazole and trimethoprim.
ã 2016 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
A prostate abscess caused by Nocardia is rare. We present the
ﬁrst case of a prostate abscess caused byNocardia farcinica in aman
who had been on long term steroids and etanercept for severe
psoriasis and psoriatic arthritis.
Case presentation
A 68year old man presented in March 2015 with a one week
history of intermittent dysuria and suprapubic pain. He had a two
day history of urinary hesitancy, fever, vomiting, diarrhoea and
dyspnoea. Three weeks previously he cut his left middle ﬁnger
whilst gardening. This became infected and required a one week
course of amoxicillin.
He has been heavily immunosuppressed for 30 years for severe
psoriasis and psoriatic arthritis. He has been on prednisolone
10mg daily and etanercept 50mg weekly for the past 5 years. His
previous immunosuppressive agents include methotrexate and
leﬂunomide. His other medical history includes asthma, hyperten-
sion, steroid-induced diabetes and atrial ﬁbrillation. There was no
history of any prostate surgery or instrumentation.
On admission he looked unwell. His observations were heart
rate 167, blood pressure 163/75mmHg, respiratory rate 22, oxygen
saturations 97% on room air and a temperature of 38.2 C. On
examination he had right base crepitations and suprapubic
tenderness. Urine analysis was positive for blood. His urine
microscopy showed 30 white blood cells but no growth. His chest
x-ray showed no consolidation. The C reactive protein was
390mg/L with a white cell count of 24.910 to 9/L. He was
empirically treated with ceftriaxone, gentamicin and ﬂucloxacillin
in the emergency department for sepsis of unknown source. His
acute medical unit admission diagnosis was likely urosepsis and
was continued on ceftriaxone only. His etanercept was held but his
prednisolone dose was increased to 37.5mg.
Two days into his admission he developed urinary retention
requiring catheterisation. A rectal exam revealed a tender prostate.
A computed tomography (CT) scan identiﬁed “a 3.633.4 cm
left prostate abscess and a possible sub-centimetre abscess
involving the right prostate gland (Fig. 1)”. His antibiotics were
then changed to intravenous ciproﬂoxacin 500mg twice a day.
On day 6 his blood cultures grew N. farcinica (taken pre-
antibiotics on day 1). The identiﬁcation was performed by 16 s
rRNA gene sequencing. Trimethoprim and sulfamethoxazole (TMP-
SMX) were additionally commenced. Two further blood cultures
taken on day 7 and 10 had no growth. ACTchest and brain found no
evidence of Nocardia seeding although a 5mm soft tissue nodule
was noted in the right lower lobe.
He responded to treatment and his inﬂammatory markers
normalised. He was discharged home after 15days on oral
ciproﬂoxacin and TMP-SMX. The etanercept was held indeﬁnitely
and prednisolone weaned back to his normal dose. He has
currently been on antibiotics for 8 months and his repeat CT
showed his prostate abscess had resolved.
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Discussion
Prostate infections are most commonly caused by Gram-
negative organisms associated with urinary tract infections or
Staphylococcus aureus from haematological dissemination from a
primary focus. There are no literature case reports of a prostate
abscess caused by Nocardia. There are 7 case reports of epidiymo-
orchitis and/or testicular abscesses caused by Nocardia and one
disseminated Nocardia infection associated with a urinary tract
infection. In all cases, except for one, the patients were
immunosuppressed with steroids [1–8].
Nocardia is characterised as a Gram positive ﬁlamentous rod
and is found worldwide in soil, decaying vegetable matter and
aquatic environments [9]. It is a slow growing organism and can
take up to 7days to be identiﬁed on blood cultures. The genus of
Nocardia is rapidly expanding and now contains more than
50 known species. Identiﬁcation of clinical isolates beyond the
genus level is important since Nocardia species differ in the clinical
spectrum of the disease they cause and their susceptibility to
antibiotics. In particular, N. farcinica tends to be more virulent
resulting in disseminated disease and increased resistance to
treatment [10–12].
Sixty percent of all reported cases of Nocardia are associated
with underlying immunosuppression [10]. The overall incidence of
Nocardia in different types of immunosuppressed populations has
been estimated to range between 0.4% and 3.6% [10]. In the
literature, solid organ transplants are the most common underly-
ing associated condition followed by HIV infection [12]. Minero
et al. found that treatment with corticosteroids was the most
important risk factor; 62% (N=23) had received corticosteroids for
a median of 3 months with a median dose of 25mg before
developing Nocardia [10].
The main route of acquisition is through direct inhalation of
airborne spores or by direct inoculation through the skin. Nocardia
involves the lung in 60–70% of cases and skin in 10%. However, it
can affect virtually any organ through haematological dissemina-
tion, most commonly the central nervous system [10,11]. Nocardia
isolation from blood cultures is rare (even with disseminated
disease) and has been associatedwith central venous catheters and
prosthetic heart valves, neither of which our patient had [12].
Nocardia bacteraemia carries a high mortality rate of 50–85%
[12,13].
Cutaneous Nocardia is characterised by one of two manifes-
tations: primary cutaneous infection via inoculation or dissemi-
nated infection with skin involvement. Primary cutaneous
infection more commonly affects immunocompetent individuals;
the most common isolated species being N. brasiliensis [14]. In our
case we presumed he acquired Nocardia through skin inoculation
whilst gardening with haematological dissemination to his
prostate. Although the most common radiological ﬁnding of
pulmonary Nocardia is a lung nodule we did not get a biopsy to
conﬁrm a tissue diagnosis as the patient was responding to
treatment [15].
General treatment recommendations for Nocardia are hindered
by lack of prospective controlled trials. TMP-SMX is recommended
as an initial empiric regimen since most studies show high rates of
susceptibility of Nocardia to this combination [12]. The duration is
prolonged to minimise risk of disease relapse; the mean duration
of treatment is 6–12 months but should be tailored to the
underlying immunosuppression and clinical progression of the
patient [15].
We accept that a limitation of this casewas thatwewere unable
to obtain a tissue diagnosis. Unfortunately, both the interventional
radiology and urology teams were reluctant to perform a trans-
rectal drainage given the high risk of a ﬁstula and further seeding.
The second limitation is that we did not culture the organism from
a second set of blood culture and this is because hewas empirically
started on broad-spectrum antibiotics on admission. Nocardia
species in blood culture is rarely considered a contaminant
especially in patients presenting with sepsis in the background
of profound immunosuppression [16].
Conclusion
Nocardia has a rising incidence due to increasing numbers of
immunosuppressed patients and improved methods of detection
[12]. Early detection and treatment of patients is clinically
important due to its high mortality. This case report serves to
highlight the importance of early, pre-antibiotic blood cultures and
the necessity for clinicians to consider unusual presentations of
opportunistic infections in immunocompromised patients.
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Fig. 1. CT scan with the white arrow pointing to the prostate abscess.
H. Scorey, S. Daniel / IDCases 5 (2016) 24–26 25
[4] Strong D, Hodges C. Disseminated nocardiosis presenting as testicular abscess.
Urology 1976;7(1):57–9.
[5] Wheeler JS, Culkin DJ, O’Connell J, Winters G. Nocardia epidiymo-orchitis in an
immunosuppressed patient. J Urol 1986;136(6):1314–5.
[6] Lopez E, Ferrero M, Lumbreras C, Gimeno C, Gonazalez-Pinto I, Palengue E. A
case of testicular nocardiosis and literature review. Eur J Clin Microbiol Infect
Dis 1994;13(4):310–3.
[7] Poisnel E, Roseau JB, Landais C, Rodriguez-Nava V, Bussy E, Gaillard T. Nocardia
veterana: disseminated infection with urinary tract infection. Braz J Infect Dis
2015;19(2):216–9.
[8] Yamaguchi H, Sekimoto E, Shirakami A, Shibata H, Ozaki S, Shigekiyo T, et al.
Testicular nocardiosis accompanied by cutaneous lesions in an
immunocompetant man. Intern Med 2013;52(1):129–33.
[9] JohnW,WilsonMD. Nocardiosis updates and clinical overview.Mayo Clin Proc
2012;87(4):403–7.
[10] MineroM,MarinM, Cercendado E, Rabadan P, Bouza E,Munoz P. Nocardiosis at
the turn of the century. Medicine 2009;88(4):250–61.
[11] Agterof MJ, Van der Bruggen T, Tersmette M, Borg EJ, Bosch van dn JM, Biesma
DH. Nocardiosis a case series and a mini review of clinical and microbiological
features. Neth J Med 2007;65(6):199–202.
[12] Brown-Elliott B, Brown J, Conville P,Wallace R. Clinical and laboratory features
of Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev
2006;19(2):259–82.
[13] Kontoyiannis DP, Ryoff K, Hooper DC. Nocardia bacteremia: report of 4 cases
and review of literature. Medicine (Baltimore) 1998;77(4):255–67.
[14] Dodiuk-Gad R, Cohen E, Ziv M, Goldstein LH, Chazan B, Shafer J, et al.
Cutaneous nocardiosis: report of two cases and review of the literature. Int J
Dermatol 2010;49(12):1380–5.
[15] Rosman Y, Grossman E, Keller N, Thaler N, ThalerM, Eciatar T, et al. Nocardiosis
a 15-year experience in a tertiary medical centre in Israel. Eur J Intern Med
2013;24(6):552–7.
[16] Esteban J, Ramos JM, Fernadez-Guerrero ML, Soriano F. Isolation of Nocardia
sp. from blood cultures in a teaching hospital. Scand J Infect Dis 1994;26
(6):693–6.
26 H. Scorey, S. Daniel / IDCases 5 (2016) 24–26
